• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

CLENBUTEROL Drug Record

  • Summary
  • Interactions
  • Claims
  • CLENBUTEROL chembl:CHEMBL49080 Approved

    Alternate Names:

    NAB-365
    CLENBUTEROL
    CLENBUTEROL HCL

    Drug Info:

    FDA Approval not approved by the FDA
    Drug Class small molecule
    Drug Indications Bronchodilator Agents
    Year of Approval not approved by the fda
    Drug Class bronchodilator agents
    (1 More Sources)

    Publications:

    Ryall et al., 2002, Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol., Am. J. Physiol. Regul. Integr. Comp. Physiol.
    Zhu et al., 2001, Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-beta-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia., Neuroscience
    Choo et al., 1992, Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation., Am. J. Physiol.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Sillence et al., 1991, Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on beta 2-adrenoceptor density in female rats., Naunyn Schmiedebergs Arch. Pharmacol.
    Mazzanti et al., 2007, A pharmacodynamic study on clenbuterol-induced toxicity: beta1- and beta2-adrenoceptors involvement in guinea-pig tachycardia in an in vitro model., Food Chem. Toxicol.
    MacDonald ML et al., 2006, Identifying off-target effects and hidden phenotypes of drugs in human cells., Nat Chem Biol
  • CLENBUTEROL   ADRB2

    Interaction Score: 5.31

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    PMIDs:
    12388476 11720783 1322047 11752352 1685013 17449161 16680159


    Sources:
    DTC TdgClinicalTrial TEND TTD

  • TdgClinicalTrial: CLENBUTEROL

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Bronchodilator Agents
    Drug Class small molecule
    FDA Approval not approved by the FDA

    Publications:

  • TEND: CLENBUTEROL

    • Version: 01-August-2011

    Alternate Names:

    Drug Info:
    Drug Class bronchodilator agents
    Year of Approval not approved by the fda

    Publications:

  • DTC: CLENBUTEROL

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL49080 ChEMBL Drug ID

    Drug Info:

    Publications:
    MacDonald ML et al., 2006, Identifying off-target effects and hidden phenotypes of drugs in human cells., Nat Chem Biol

  • TTD: Clenbuterol

    • Version: 2020.06.01

    Alternate Names:
    D0X5NX TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL49080

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21